AYATRIS
Human Biology
on a Chip.
The future of predictive drug development.
The problem
Animal data drives most preclinical decisions. But it doesn't predict human biology.
Species differences routinely mask the toxicity and efficacy signals that only surface once a program reaches human trials.
By then, the cost of being wrong is measured in years and millions. The FDA Modernization Act now allows non-animal data in regulatory submissions — opening the door to models built on real human tissue.
The platform
Three chip systems.
One vascular architecture.
01 / 03
Body-on-a-Chip
Modular microfluidic system with perfused capillary networks connecting multiple organ types.
Contact us for more information →
02 / 03
Forebrain-on-a-Chip
Multilayered gradient device generating topographically organized cerebral organoids.
Contact us for more information →
03 / 03
Placenta-on-a-Chip
Stem-cell-derived placental organoids integrated with vascular microfluidics.
Contact us for more information →
